By Emon Reiser
Haemonetics appointed Dr. Frank Chan, a longtime Medtronic executive, as vice president and chief operating officer, effective April 7.
The Boston-based blood collection and transfusion services company on Monday said Chan has more than 25 years of experience in the medical device and healthcare technology sectors. He was recently president of acute care and monitoring at Medtronic, where he has held leadership positions since 2015. Chan will report to Haemonetics Chief Executive Officer Chris Simon.
Haemonetics also promoted Roy Galvin, currently president of the company's global plasma and blood center, to chief commercial officer, effective immediately. His expanded role gives him responsibility over the company's global hospital business, and its global plasma and blood center business. Stewart Strong will continue in his role as president of global hospital for Haemonetics until April 1, and then transition to become an adviser to the CEO for a temporary period.
Write to Emon Reiser at emon.reiser@wsj.com
(END) Dow Jones Newswires
March 03, 2025 18:01 ET (23:01 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。